Liver parenchymal cells were isolated from adult rats and cultured in collagen-coated plastic petri dishes in serum-free medium. Glucagon induced 4 to 5-fold increases in a-aminoisobutyric acid (AIB) transport within 6 hr. Dexamethasone had no direct effect on AIB transport but greatly potentiated the induction by glucagon ("permissive effect"). Levels of 3':5'-cyclic AMP increased 30-to 100-fold within 30 min after glucagon addition to cultures that had been treated with dexamethasone, and dibutyryl cyclic AMP mimicked the glucagon induction of AIB transport. Additionally, dexamethasone exerted a "permissive" effect on induction of AIB transport by dibutyryl cyclic AMP, whereas the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine induced AIB transport only in cultures that had been treated with dexamethasone. Induction of AI transport was not dependent upon the continued presence of glucagon, but induced AIB transport activity decayed to uninduced levels within 3-4 hr after glucagon removal. The protein synthesis inhibitors puromycin and cycloheximide inhibited both induction and decay of glucagon-induced AIB transport, but had a stabilizing effect if added once induction or decay had commenced. Unlike cycloheximide, the inhibitory effect of puromycin on the glucagon induction of AIB transport was reversible.
glucagon induction of AIB transport. Additionally, dexamethasone exerted a "permissive" effect on induction of AIB transport by dibutyryl cyclic AMP, whereas the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine induced AIB transport only in cultures that had been treated with dexamethasone. Induction of AI transport was not dependent upon the continued presence of glucagon, but induced AIB transport activity decayed to uninduced levels within [3] [4] hr after glucagon removal. The protein synthesis inhibitors puromycin and cycloheximide inhibited both induction and decay of glucagon-induced AIB transport, but had a stabilizing effect if added once induction or decay had commenced. Unlike cycloheximide, the inhibitory effect of puromycin on the glucagon induction of AIB transport was reversible.
Previous reports from this (1-4) and other (5-7) laboratories have established methodology for the isolation and primary culture of liver parenchymal cells from adult rats. These cells can be cultured in serum-free medium (2-4) and do not divide even in medium supplemented with serum (1, 2) . However, various biochemical activities are inducible under appropriate conditions. Ornithine decarboxylase activity (EC 4.1.1.17) is induced by insulin but not by hydrocortisone (2) , whereas dexamethasone (DEX), a synthetic glucocorticoid, will induce tyrosine aminotransferase (EC 2.6.1.5) activity (1, 2) . While DEX does not by itself affect amino acid transport in this system (8) , in contrast to results with liver in vivo (ref. 9 ; and see refs. 8 and 10), DEX greatly potentiates the induction of a-aminoisobutyric acid (AIB) transport by glucagon. This action was recognized as a "permissive" effect (8) . Glucagon lowered the Km for transport, whereas DEX exerted the "permissive" effect by raising the Vmax (10) . Thus, glucagon may induce the synthesis of a new amino acid transport system or effect an alter- (12) .
Protocol. The specific protocol used in this investigation was as follows:
(i) Cells were isolated by a modification of the collagenase perfusion technique of Berry and Friend (1-3, 6, 13) (yield: 300 to 600 X 106 cells per liver).
(ii) Cells were suspended at 1 X 106 cells per ml in a modified Waymouth's MB 752/1 medium (WO/BA-M2, see refs. 3 and 4) . WO/BA-M2 is serum-free, and was supplemented with insulin (0.50 ,g/ml) and gentamycin (Schering) (50 Ag/ml) (4).
(iii) Cells in 3-ml volumes were inoculated into 100-150 60 mm plastic culture dishes that had been coated with thin layers of rat-tail collagen (2) (3) (4) . About 50% of the cells attach within 3-4 hr.
(iv) Medium was changed to fresh WO/BA-M2 plus insulin and gentamycin at 3-4 hr after the initial inoculation.
(v) At 30 hr, medium was changed to Swim's S-77 (14) , which is chemically defined and contained no insulin or serum. Except where indicated, the cells were not exposed to additional medium changes.
(vi) At about 36 hr, induction of AIB transport was begun with 1 ,AM DEX ± 0.2 ,M glucagon added according to timing schedules indicated (unless otherwise specified these concentrations of hormones were used); control plates contained no hormone.
(vii) Experiments described herein were begun with zero time understood to be 45-48 hr after the initial plating. All further treatments and samplings were done during the next 5-12 hr. AIB Transport Determination. Methods used for determining AIB transport rates have been published (4, 8, 9) , except that in this study AIB uptake was measured during a 4-min exposure to 2-3 ml of Hank's N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Hepes) buffered salt solution minus glucose (found to be unnecessary) containing (4) that is biochemically distinct from that induced by glucagon (8, 10) . The glucagon-diluting solution alone had no effect on AIB transport.
All reagents were dissolved in water or saline except for glucagon (dissolved in diluting solution), iBuMeXan (dissolved in 39% EtOH), and CX (dissolved in H20 containing HCO to pH 2),and were added to culture dishes (3 ml of medium) in 10-Al aliquots.
RESULTS Induction of AIB Transport by Glucagon, Bt2cAMP, and iBuMeXan. Fig. 1 shows the induction of AIB transport by glucagon in liver cells pretreated with medium alone or containing 1 ,uM DEX. During the first hour of incubation with glucagon, no appreciable increase in AIB transport was observed. However, at times after this increased rates of AIB transport were evident in glucagon-treated cultures and were most elevated in cultures treated with glucagon + DEX (Fig.  1 ). These data confirm previous reports from this laboratory where the difference between the rates of AIB transport in cells treated with glucagon + DEX and glucagon alone was recognized as a DEX "permissive" effect (8) .
The level of glucagon used in these studies is 0.2 ,M, which gives the maximal response. Other experiments have shown that 1 nM glucagon will induce measurable AIB transport as well as cAMP in these cells. Moreover, both hydrocortisone and corticosterone elicit "permissive" effects on this system that are similar to that of DEX, and all three glucocorticoids have effected detectable responses at concentrations as low as 1 nM. Fig. 1 also shows cAMP data for the cells that had been treated with DEX and then exposed to glucagon + DEX. cAMP was induced by glucagon from a basal level of about 2 pmol/mg of protein to about 200 pmol/mg of protein within 30 min of addition. By 1 hr, cAMP had fallen to about one-third of the 30-min level, but at 11 hr cAMP in these cells was still about 10 times the basal level. We do not yet know how DEX pretreatment affects cAMP induction by glucagon because of experimental variation: with some cell preparations, DEX pretreatment appeared to have little effect on cAMP induction by glucagon, as reported previously (11), but more recent experiments indicate that DEX pretreatment may under some circumstances slightly lower the basal and the glucagon-induced cAMP levels.
The data of Fig. 1 establish that 11 hr after glucagon addition cAMP values had stabilized at relatively low levels, whereas AIB transport had achieved maximal or near-maximal levels. Other experiments (not shown) established that medium from cells incubated 12 hr with glucagon + DEX induced 50-fold increases in cAMP when added to liver cell cultures not previously exposed to glucagon, thus indicating that biologically active glucagon was still present in such medium. Moreover, cAMP was not inducible in the cells treated for 12 hr with glucagon + DEX when they were again exposed to glucagon in fresh medium, indicating that the decline in cAMP that follows peak levels ( Fig. 1) is the result of a change in the cells and not of degradation of glucagon.
In an effort to further characterize this system with respect to possible involvement with cAMP, studies comparing the effects of Bt2cAMP and iBuMeXan, a potent inhibitor of phosphodiesterase activity (18) , with the increase effected by glucagon were conducted. Fig. 2 showns typical results obtained in these studies. Interestingly, Bt2cAMP closely mimicked glucagon with respect to time course as well as level of induction of AIB transport. The similarity between the effects of glucagon and Bt2cAMP extended to liver cells that had been treated with medium alone or that contained DEX (Fig. 2) not treated with DEX have thus far been unsuccessful. Therefore, it appears at this time that iBuMeXan cannot induce AIB transport in this system unless DEX is also present. While glucagon induced cAMP levels by 30-to 100-fold in these cells (Fig.  1) , iBuMeXan induces only 3-to 4-fold increases in cAMP levels above basal (not shown); this could be important in interpreting the data of Fig. 2 .
Effects of CX and PR on Induction of AIR Transport by
Glucagon. Fig. 3 shows the effect on AIB transport of adding the protein synthesis inhibitors, CX or PR, to liver cells at various times after glucagon addition. Both inhibitors blocked the induction if added with the glucagon or 30 m4 later. After this time, adding either CX or PR appeared to retard further induction, but the level of transport activity at the time of inhibitor addition also did not decline (Fig. 3) .
In an effort to determine whether critical events involving protein synthesis might occur during the first 30 mmn after glucagon addition, the experiment shown in Fig. 4 was conducted. Liver cells were exposed to glucagon d CX or PR for MP o 30 mm, and then both the inhibitor and the glucagon were removed. As shown in Fig. 4 (Fig. 4) 1 However, the presence of CX during the 30-mmu exposure to glucagon, unlike PR, reduced the level of induction of AIB transport (Fig. 4) . Thus, it appears that an irreversible PR-sensitive step does not occur during the first 30 mm after glucagon addition, but the results with CX are less clear.
Decay of AIR Transport When Glucagon Is Removed. Fig.   5 establishes that when liver cells previously treated with glucagon + DEX for 12 hr were exposed to fresh medium containing no hormones, AIB transport activity decays to uninduced levels within about 4 hr. Addition of DEX to the medium did not prevent this decay (Fig. 5) . In contrast, medium containing glucagon alone appeared to protect the fully induced AIB transport system (Fig. 5) . Tews et al. (19) , using liver slices, also found that glucagon-induced AIB transport rapidly decayed when glucagon was removed.
Effect of CX and PR on Decay of AIR Transport. Fig. 6 shows the effect of CX and PR on the decay of the fully induced ATE-transport system when glucagon + DEX are removed. If added simultaneously with the change to medium minus hormones, AIB transport activity did not decay to the uninduced Z . (Fig. 6) . If the inhibitors were added 1 hr after removal of glucagon + DEX, by which time some decay had occurred, further decay was substantially retarded. However, at 2 hr after medium change only CX delayed the decrease in AIB transport activity towards the uninduced level (Fig. 6 ).
DISCUSSION
Paradoxical effects of inhibitors of protein synthesis (e.g., prevention of decay or apparent induction) on various biochemical activities in eukaryotic systems have been reported from several laboratories (20) (21) (22) (23) (24) (25) . Some of this work has been conducted with the whole animal where multiple variables must be contended with. For example, Levine et al. (20) found that the primary reason for the increase in renal ornithine decarboxylase activity after CX administration was the stimulation of the release of pituitary hormone, which, in turn, induced the enzyme. However, Kenney (21) showed that CX or PR stabilized hepatic tyrosine aminotransferase by preventing both its synthesis and decay, and this model appears to be somewhat applicable to the phenomena reported in this communication.
The data of Figs. 3 and 6 argue that both the induction and decay of glucagon-induced amino acid transport in cultured liver cells is dependent upon de novo protein synthesis. Moreover, the fact that CX or PR can prevent decay to uninduced levels even after decay has commenced (Fig. 6 , data at 1 hr) implies that the decay system for AIB transport may itself be subject to rapid decay by mechanisms not blocked by CX or PR.
Whether degradation or inactivation (24) A logical extension of this model is to suppose that glucagon might inhibit the decay system for AIB transport by specifically inhibiting the synthesis of one or more proteins involved in decay. Wicks (26) has recently reviewed the literature demonstrating that glucagon (and Bt2cAMP) of some hepatic enzymes under certain circumstances, and has discussed this phenomenon in relation to the inhibition of the synthesis of specific proteins by glucagon through cAMP. However, it is also possible that the plateau level of AIB transport represents a balance between synthesis and decay (both of which are blocked by CX or PR, as indicated by our data). Such a model need only assume that continued synthesis is dependent upon glucagon whereas degradation is constant in the presence or absence of glucagon. Distinction between these hypotheses must await further experimentation. The data of Fig. 4 are interesting from several viewpoints. First, Fig. 4 establishes that glucagon can be removed from the medium before an increase in AIB transport has appeared and still effect a 4-to 5-fold induction at later time points. These findings should be contrasted with the data of Figs. 5 and 6, where removal of glucagon from fully induced cells resulted in a decay of AIB transport to ininduced levels within 3-4 hr.
The data of Fig. 4 further show that the presence of PR in the medium during the 3S-min exposure to glucagon had essentially a negligible effect on AIB transport induction at 2, 4, and 6 hr, whereas continuous exposure to PR from time 0 completely inhibited the glucagon induction (Fig. 3) for the lack of "reversibility" of CX in this system. Simply stated, CX might interfere with transcription forming mRNA as well as translation of mRNA into protein. Fig. 1 and ref. 11 establish that glucagon rapidly induces large increases in intracellular cAMP. Moreover, Bt2cAMP effectively replaces glucagon in the induction of AIB transport (Fig. 2, and ref. 8 ) and the effects of glucagon and Bt2cAMP are not additive (10) . However, Fig. 2 shows that iBuMeXan induced AIB transport only in cells that had been treated with DEX, an observation that we have not explained. In another study (ref. 28 , and manuscript in preparation), we found that epinephrine induces AIB transport through a cAMP-independent mechanism, possibly cGMP (29) , a finding in keeping with related reports of other investigators (32) (33) (34) . By analogy, it is prudent at this time to conclude that cAMP induction by glucagon may not be required for the induction of AIB transport in our system.
Finally, it must be emphasized that we have tested several different media and thus far Swim's S-77 medium (14) has given both the maximal and most consistent inductions of AIB transport with glucagon. Specifically, we have found Leibovitz's L-15 medium (33) and WO/BA-M2 (see Materials and Methods) to be less satisfactory than Swim's S-77 medium in these studies, although we routinely use the WO/BA-M2 medium for culturing liver cells during the first 24 hr after isolation (prior to DEX or glucagon exposure). These differences may be related to amino acid concentration and, in the case of L-15 medium, to the fact that it is designed to be used in air as opposed to S-77 and WO/BA-M2, which are designed for an atmosphere of 95% air-5% CO2.
Our results with Leibovitz's L-15 medium may in part explain why Ayala and Canonico (34), who used this medium for culturing adult rat liver parenchymal cells, observed only very small increases in AIB transport after glucagon addition. We have also previously reported effect of medium on ornithine decarboxylase activity (2) .
